• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺及锁骨上区放疗患者中,上切线/锁骨上匹配线位置变化对Ⅲ级腋窝/腋窝尖部剂量覆盖的影响

Effects of variable placement of superior tangential/supraclavicular match line on dosimetric coverage of level III axilla/axillary apex in patients treated with breast and supraclavicular radiotherapy.

作者信息

Garg Amit K, Frija Erik K, Sun Tzouh-Liang, Strom Eric A, Perkins George H, Oh Julia L, Yu Tsu-Kuan, Woodward Wendy A, Tereffe Welella A, Salehpour Mohammad, Buchholz Thomas A

机构信息

Department of Radiation Oncology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

出版信息

Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):370-4. doi: 10.1016/j.ijrobp.2008.04.045.

DOI:10.1016/j.ijrobp.2008.04.045
PMID:18676090
Abstract

PURPOSE

To determine the differences in dosimetric coverage of the Level III axillary node target as a function of the superior tangential/supraclavicular match line in breast cancer patients undergoing with tangential breast and supraclavicular fossa radiotherapy.

METHODS AND MATERIALS

The data from 20 consecutive breast cancer patients who were treated with breast conservation surgery and Level I and II axillary dissection followed by radiotherapy to the undissected Level III axilla/supraclavicular fossa were retrospectively analyzed. The nodal volumes were delineated from the computed tomography simulation data set. Three composite treatment plans were generated for each patient according to the placement of the match line.

RESULTS

Coverage of the contoured Level III/axillary apex varied significantly with respect to the ipsilateral clavicular head, depending on the placement of the superior tangential/supraclavicular match line. The mean volume of the Level III/axillary apex covered by the 90% isodose line (45 Gy) was 100% for caudal placement of the match line, significantly greater than the 92% for intermediate placement (bisecting the clavicular head; p = 0.001) and the 68% for cranial placement with respect to the clavicular head (p < 0.001).

CONCLUSION

Placement of the superior tangential/supraclavicular match line caudal to the clavicular head results in statistically improved dosimetric coverage of the Level III axilla/axillary apex in breast cancer patients undergoing tangential/supraclavicular radiotherapy.

摘要

目的

确定在接受乳腺切线野和锁骨上窝放疗的乳腺癌患者中,III级腋窝淋巴结靶区剂量覆盖情况随上切线/锁骨上匹配线位置变化的差异。

方法和材料

回顾性分析20例连续乳腺癌患者的数据,这些患者接受了保乳手术及I级和II级腋窝淋巴结清扫,随后对未清扫的III级腋窝/锁骨上窝进行放疗。根据计算机断层扫描模拟数据集勾勒出淋巴结体积。根据匹配线的位置为每位患者生成三个综合治疗计划。

结果

根据上切线/锁骨上匹配线的位置,III级/腋窝尖部的轮廓覆盖范围相对于同侧锁骨头部有显著差异。匹配线下位放置时,90%等剂量线(45 Gy)覆盖的III级/腋窝尖部平均体积为100%,显著大于匹配线中位放置(平分锁骨头部)时的92%(p = 0.001)以及匹配线上位放置时相对于锁骨头部的68%(p < 0.001)。

结论

在上切线/锁骨上匹配线置于锁骨头部下方时,接受切线野/锁骨上放疗的乳腺癌患者III级腋窝/腋窝尖部的剂量覆盖在统计学上有改善。

相似文献

1
Effects of variable placement of superior tangential/supraclavicular match line on dosimetric coverage of level III axilla/axillary apex in patients treated with breast and supraclavicular radiotherapy.乳腺及锁骨上区放疗患者中,上切线/锁骨上匹配线位置变化对Ⅲ级腋窝/腋窝尖部剂量覆盖的影响
Int J Radiat Oncol Biol Phys. 2009 Feb 1;73(2):370-4. doi: 10.1016/j.ijrobp.2008.04.045.
2
Axillary lymph node dose with tangential breast irradiation.乳腺切线照射时腋窝淋巴结的剂量
Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):358-64. doi: 10.1016/j.ijrobp.2004.06.006.
3
Different radiation techniques to deliver therapeutic dose to the axilla in patients with sentinel lymph node-positive breast cancer: Doses, techniques challenges and clinical considerations.前哨淋巴结阳性乳腺癌患者腋窝给予治疗剂量的不同放射技术:剂量、技术挑战及临床考量
Cancer Radiother. 2018 Dec;22(8):767-772. doi: 10.1016/j.canrad.2018.02.002. Epub 2018 Oct 27.
4
Breast cancer regional radiation fields for supraclavicular and axillary lymph node treatment: is a posterior axillary boost field technique optimal?用于锁骨上和腋窝淋巴结治疗的乳腺癌区域放疗野:腋窝后野追加技术是否最佳?
Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):86-91. doi: 10.1016/j.ijrobp.2008.07.016. Epub 2008 Sep 19.
5
Coverage of axillary lymph nodes with high tangential fields in breast radiotherapy.乳腺癌放射治疗中采用切线野覆盖腋窝淋巴结。
Br J Radiol. 2010 Dec;83(996):1072-6. doi: 10.1259/bjr/25788274.
6
The application of PET-CT to post-mastectomy regional radiation therapy using a deformable image registration.应用 PET-CT 行乳房切除术后区域放射治疗的形变图像配准技术。
Radiat Oncol. 2013 Apr 29;8:104. doi: 10.1186/1748-717X-8-104.
7
Analysis of axillary coverage during tangential radiation therapy to the breast.乳腺癌切线放射治疗期间腋窝覆盖范围的分析。
Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):163-8. doi: 10.1016/j.ijrobp.2004.04.065.
8
Comparison of three-dimensional versus intensity-modulated radiotherapy techniques to treat breast and axillary level III and supraclavicular nodes in a prone versus supine position.比较三维适形放疗技术与调强放疗技术治疗俯卧位与仰卧位乳腺癌及腋窝 III 水平和锁骨上淋巴结的疗效。
Radiother Oncol. 2012 Jan;102(1):74-81. doi: 10.1016/j.radonc.2011.09.008. Epub 2011 Oct 10.
9
Matching supraclavicular fields to the extent of axillary surgery in women prescribed radiotherapy for early stage carcinoma of the breast.在接受早期乳腺癌放射治疗的女性中,使锁骨上野与腋窝手术范围相匹配。
Clin Oncol (R Coll Radiol). 2005 Feb;17(1):32-8. doi: 10.1016/j.clon.2004.09.011.
10
Clinical investigation: regional nodal failure patterns in breast cancer patients treated with mastectomy without radiotherapy.临床研究:接受乳房切除术且未接受放疗的乳腺癌患者区域淋巴结转移模式
Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1508-13. doi: 10.1016/j.ijrobp.2005.05.044. Epub 2005 Sep 19.

引用本文的文献

1
Initial Clinical Experience of Cherenkov Imaging in External Beam Radiation Therapy Identifies Opportunities to Improve Treatment Delivery.切伦科夫成像在外照射放疗中的初步临床经验确定了改善治疗实施的机会。
Int J Radiat Oncol Biol Phys. 2021 Apr 1;109(5):1627-1637. doi: 10.1016/j.ijrobp.2020.11.013. Epub 2020 Nov 20.
2
How do I deal with the axilla in patients with a positive sentinel lymph node?对于前哨淋巴结阳性的患者,我该如何处理腋窝?
Curr Treat Options Oncol. 2011 Dec;12(4):389-402. doi: 10.1007/s11864-011-0170-4.